At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 200 enrolled
Drug / intervention
Esmolol +1 moredrug
Likely dose
Esmolol 3 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Esmolol in Cardiac Surgery. A Randomized Controlled Trial With Clinical
In Brief
A Phase 4 clinical trial evaluating Esmolol and Placebo for Cardiac Surgery. Completed, enrolled 200 participants across 1 site.
Detailed Summary
This large randomized double-blind clinical trial (esmolol vs placebo) will enroll patients undergoing cardiac surgery to study the additive cardiac protection of this therapeutic strategy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Surgery
CountriesItaly
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2009
First PostedAug 2009
Primary CompletionMay 2018
Study CompletionJun 2018
TodayJul 2026
First PostedAug 14, 2009
Enrollment StartAug 1, 2009
Primary CompletionMay 1, 2018
Study CompletionJun 1, 2018
TodayJul 2, 2026
Enrollment to primary: 8.8 yearsPosted 16.9 years ago
Interventions
Esmololdrug
esmolol (1-3 mg/kg) during cardiac surgery
Placebodrug
normosaline (same ml of the study drug)